Clinical Trial Update: Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating cobalt's role in excessive erythrocytosis among high-altitude residents in Cerro de Pasco, Peru.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythrocytosis
• Mountain Sickness

Drugs mentioned

• Cobalt

Snippet

Sponsor: University of Colorado, Denver | Conditions: Erythrocytosis, Mountain Sickness | Phase 1, Phase 2 | Status: COMPLETED